Pharma Journalist 9038 posts 0 comments

ACADIA Pharmaceuticals Inc. and Neuren Pharmaceuticals Limited announced that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Disease (RPD) designation to trofinetide…
Read More...

MilliporeSigma launched its LANEXO Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and…
Read More...

Eli Lilly and Company issued the following statement today regarding the novel coronavirus: Among the concerns raised due to the impact of the novel coronavirus is whether patients…
Read More...

Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced that study enrolment of its international ARGOS-SC01 clinical study was completed with the…
Read More...

CYTOO announced that it has entered into a research collaboration aimed at selecting a gene therapy candidate for a rare muscle disorder with Asklepios BioPharmaceutical, Inc. (AskBio),…
Read More...

AstraZeneca announced that it has completed the previously communicated agreement with Atnahs Pharma (Atnahs) to divest its global commercial rights to Inderal (propranolol), Tenormin…
Read More...

Mateon Therapeutics, Inc. dedicated to development OT-101, a TGF-Beta antisense drug candidate, provided an update on its rapid antiviral response program initially targeting the…
Read More...

SMi Reports: Conference highlights for AI in Drug Discovery conference taking place in London, this March. With less than 2 weeks to go for the highly anticipated AI in Drug…
Read More...

Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the…
Read More...

Gilead Sciences, Inc. and Forty Seven, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Forty Seven for $95.50 per share…
Read More...